These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 1032819

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 3. Urinary hormone excretion patterns during low-dose progestogen administration.
    Varga L, Tamme E.
    J Int Med Res; 1975 Jul; 3(2):63-72. PubMed ID: 1140508
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical investigation of the biological effects of a new combination low-dose oral contraceptive ('Ovostat E').
    Tarkkila T, Hulkko S, Alapiessa U, Kauraniemi T.
    Curr Med Res Opin; 1977 Jul; 5(3):247-51. PubMed ID: 162661
    [Abstract] [Full Text] [Related]

  • 7. Effects of a low-oestrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids.
    Elstein M, Briston PG, Jenkins M, Kirk D, Miller H.
    Br Med J; 1974 Jan 05; 1(5896):11-3. PubMed ID: 4808812
    [Abstract] [Full Text] [Related]

  • 8. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
    Niaraki MA, Moghissi KS, Borin K.
    Fertil Steril; 1981 Mar 05; 35(3):284-8. PubMed ID: 6781938
    [Abstract] [Full Text] [Related]

  • 9. Control of fertility with oral medication.
    Diddle AW, Watts GF, Gardner WH, Williamson PJ.
    West J Surg Obstet Gynecol; 1964 Mar 05; 72():222-9. PubMed ID: 12305556
    [Abstract] [Full Text] [Related]

  • 10. [Effect of oral contraceptive on the pituitary and plasma L.H. levels and on the hypothalamic LH-RH level (author's transl)].
    Sato N, Yanaihara T, Kanazawa M, Okinaga S, Arai K.
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug 20; 52(8):845-50. PubMed ID: 797581
    [Abstract] [Full Text] [Related]

  • 11. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 12. Temporal relationship between Uniplant insertion and changes in cervical mucus.
    Barbosa IC, Coutinho E, Hirsch C, Ladipo OA, Olsson SE, Ulmsten U.
    Contraception; 1996 Oct 01; 54(4):213-7. PubMed ID: 8922874
    [Abstract] [Full Text] [Related]

  • 13. Effect of the norethisterone minipill on the plasma levels of biologically and immunologically active luteinizing hormone in women.
    Balogh A, Robertson DM, Diczfalusy E.
    Acta Endocrinol (Copenh); 1979 Nov 01; 92(3):428-36. PubMed ID: 517047
    [Abstract] [Full Text] [Related]

  • 14. The effect of norethisterone capsules on the pituitary-ovarian axis.
    Nuttall ID, Elstein M, Fahmy DR.
    Contraception; 1982 Jan 01; 25(1):51-7. PubMed ID: 6800692
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Contraceptive mechanism of microdose norethindrone.
    Moghissi KS, Syner FN, McBride LC.
    Obstet Gynecol; 1973 Apr 01; 41(4):585-94. PubMed ID: 4735314
    [Abstract] [Full Text] [Related]

  • 17. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R, Lähteenmäki P, Luukkainen T, Tuominen J.
    Fertil Steril; 1993 Oct 01; 60(4):610-5. PubMed ID: 8405512
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 2. Maintenance of ovarian function in patients with megestrol acetate implants.
    Benagiano G, Ermini M, Carenza L, Donini P.
    Acta Endocrinol (Copenh); 1973 Jun 01; 73(2):347-59. PubMed ID: 4740834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.